{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:50:44Z","timestamp":1772805044730,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1053\/j.ajkd.2003.09.027","type":"journal-article","created":{"date-parts":[[2004,1,7]],"date-time":"2004-01-07T05:55:13Z","timestamp":1073454913000},"page":"10-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis"],"prefix":"10.1053","volume":"43","author":[{"given":"Peter","family":"Heering","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"M\u00fcllejans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Ivens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingeborg","family":"Z\u00e4uner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"F\u00fcnfst\u00fcck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frieder","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard K","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Schollmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teut","family":"Risler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Grabensee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2003.09.027_BIB1","first-page":"213","article-title":"The long-term prognosis of patients with focal segmental glomerulosclerosis","volume":"10","author":"Cameron","year":"1978","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0272-6386(12)80128-4","article-title":"Primary focal segmental glomerulosclerosis","volume":"23","author":"Korbet","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB3","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM197609302951402","article-title":"Chlorambucil treatment of frequently relapsing nephrotic syndrome","volume":"295","author":"Grupe","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB4","first-page":"149","article-title":"Cyclophosphamide therapy in focal segmental glomerular sclerosis","volume":"140","year":"1983","journal-title":"Eur J Pediatr"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s004670050167","article-title":"Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children","volume":"10","author":"Tarshish","year":"1996","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB6","first-page":"84","article-title":"Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis","volume":"43","author":"Tune","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB7","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0002-9343(87)90155-0","article-title":"Evidence suggesting undertreatment in adults with idiopathic focal segmental glomerulosclerosis in adults","volume":"82","author":"Pei","year":"1987","journal-title":"Am J Med"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB8","first-page":"413","article-title":"Therapy of membranous glomerulonephritis with a nephrotic syndrome. 5 years follow up of a prospective randomized multicenter study","volume":"6","author":"Braun","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000167436","article-title":"Treatment of idiopathic membranous nephropathy unresponsive to methylprednisolone and chlorambucil with cyclosporin","volume":"7","author":"DeSanto","year":"1987","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB10","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/BF01727848","article-title":"Cyclosporin A treatment in children with minimal nephrotic syndrome and focal segmental glomerulosclerosis","volume":"66","author":"Brodehl","year":"1988","journal-title":"Klin Wochenschrift"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2003.09.027_BIB11","first-page":"48","article-title":"Safety and tolerability of CsA in idiopathic nephrotic syndrome","volume":"135","year":"1991","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1681\/ASN.V72290","article-title":"Mechanism of the antiproteinuric effect of CsA in membranous nephropathy","volume":"7","author":"Ambavalan","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1055\/s-2001-17603","article-title":"Influence of cyclosporin on renal function in patients with glomerulonepritis","volume":"126","author":"Heering","year":"2001","journal-title":"Deutsche Med Wochenschrift"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/cs0820641","article-title":"Effect of cyclosporin on glomerular barrier function in the nephrotic syndrome","volume":"82","author":"Zietse","year":"1992","journal-title":"Clin Science"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB15","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1056\/NEJM199206183262502","article-title":"Risk factors for CsA induced neuropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases","volume":"326","author":"Feutren","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF01713009","article-title":"CsA associated nephropathy in patients with autoimmune disease","volume":"66","author":"Mihatsch","year":"1988","journal-title":"Klin Wochenschrift"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB17","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/ki.1988.38","article-title":"The long term course of CsA associated chronic nephropathy","volume":"33","author":"Myers","year":"1988","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB18","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1046\/j.1523-1755.1999.00778.x","article-title":"A randomized trial of cyclosporine in patients with steroid resistant focal segmental glomerulosclerosis","volume":"56","author":"Cattran","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB19","first-page":"375","article-title":"The efficacy of cyclosporin A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis","volume":"43","author":"Lee","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB20","first-page":"37","article-title":"Treatment of adult idiopathic nephrotic syndrome with cyclosporin A","volume":"3","author":"Meyrier","year":"1991","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB21","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/ki.1994.189","article-title":"Long-term renal tolerance of cyclosporin A treatment in adult nephrotic syndrome","volume":"45","author":"Meyrier","year":"1994","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB22","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1681\/ASN.V541049","article-title":"CsA in the treatment of idiopathic nephrosis","volume":"5","author":"Niaudet","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1681\/ASN.V32254","article-title":"Severe hypercholesteremia inhibits Cyclosporin A efficacy in a dose dependant manner in children with nephrotic syndrome","volume":"3","author":"Ingulli","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB24","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1681\/ASN.V5101820","article-title":"Aggressive, long term CsA (CSA) therapy in refractory nephrotic syndrome (NS) blunts the progression of focal segmental glomerulosclerosis (FSGS) to end stage renal disease (ESRD)","volume":"5","author":"Ingulli","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB25","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/ki.1993.194","article-title":"A randomized trial of CsA in steroid resistant idiopathic nephrotic syndrome","volume":"43","author":"Ponticelli","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB26","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0272-6386(99)70384-7","article-title":"Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?","volume":"34","author":"Ponticelli","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF02937238","article-title":"The use of cyclosporin A in adult nephrotic syndrome","volume":"159","author":"Green","year":"1990","journal-title":"Ir J Med Sci"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB28","first-page":"1286","article-title":"Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome","volume":"8","author":"McCauley","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB29","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/ndt\/13.8.2013","article-title":"Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosis","volume":"13","author":"Haas","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB30","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/0272-6386(95)90120-5","article-title":"Focal segmental glomerular sclerosis in adults","volume":"25","author":"Rydel","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2003.09.027_BIB31","first-page":"53","article-title":"The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study","volume":"36","author":"Banfi","year":"1991","journal-title":"Clin Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638603013647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638603013647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:22:09Z","timestamp":1759454529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638603013647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0272638603013647"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2003.09.027","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2003.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}